Kura Oncology Inc.

NASDAQ: KURA · Real-Time Price · USD
7.33
0.73 (11.06%)
At close: Aug 15, 2025, 3:59 PM
7.56
3.21%
After-hours: Aug 15, 2025, 07:56 PM EDT

Kura Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
15.29M 14.11M 53.88M n/a n/a n/a 1.27M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
224K n/a 204K 208K 202K 234K 214K 216K 213K 206K 206K n/a 183K 177K 166K 160K 124K 108K
Gross Profit
15.06M 14.11M 53.68M -208K -202K -234K 1.06M -216K -213K -206K -206K n/a -183K -177K -166K -160K -124K -108K
Operating Income
-72.67M -64.7M -22.45M -59.88M -56.4M -54.45M -46.76M -42.47M -40M -36.77M -35.36M -36.59M -34.77M -32.45M -32.74M -33.68M -33.65M -30.9M
Interest Income
6.93M 7.88M 5.66M 5.89M 5.97M 5.33M 4.37M 4.28M 3.22M 2.86M 2.27M 1.09M 564K 329K 295K 311K 290K 310K
Pretax Income
-66.12M -57.2M -17.2M -54.4M -50.84M -49.52M -42.79M -38.6M -37.17M -34.07M -33.11M -35.5M -34.77M -32.45M -32.74M -33.37M -33.66M -30.69M
Net Income
-66.12M -57.43M -19.22M -54.4M -50.84M -49.52M -42.79M -38.6M -37.17M -31M -33.34M -35.5M -35.33M -32.78M -32.74M -33.37M -33.66M -30.69M
Selling & General & Admin
25.17M 22.84M 24.07M 18.18M 16.48M 17.95M 14.02M 13.14M 11.82M 11.37M 12.49M 11.62M 11.07M 11.87M 12.08M 11.31M 12.57M 10.57M
Research & Development
62.78M 55.97M 52.27M 41.7M 39.73M 36.27M 32.53M 29.33M 28.18M 25.19M 22.67M 24.97M 24.26M 20.91M 20.96M 22.37M 21.07M 20.32M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 295K n/a n/a 8K
Operating Expenses
87.95M 78.81M 76.34M 59.88M 56.2M 54.22M 46.55M 42.47M 40M 36.57M 35.16M 36.59M 35.33M 32.78M 33.04M 33.68M 33.65M 30.9M
Interest Expense
391K 382K 403K 412K 406K 398K 394K 404K 387K 364K 229K n/a n/a n/a n/a n/a 306K 108K
Selling & Marketing Expenses
n/a n/a n/a n/a -202K -234K -214K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
87.95M 78.81M 76.34M 59.88M 56.4M 54.45M 46.76M 42.47M 40M 36.57M 35.16M 36.59M 35.33M 32.78M 33.04M 33.68M 33.65M 30.9M
Income Tax Expense
n/a 226K 2.02M n/a n/a n/a n/a n/a -213K -3.07M 229K n/a 564K 329K -166K 311K 290K 116K
Shares Outstanding (Basic)
87.59M 87.42M 87.14M 86.95M 86.64M 83.91M 77.34M 77.24M 69.8M 68.4M 67.78M 66.89M 66.67M 66.61M 66.55M 66.35M 66.28M 66.22M
Shares Outstanding (Diluted)
87.59M 87.42M 87.14M 86.95M 86.64M 83.91M 77.34M 77.24M 69.8M 68.4M 67.78M 66.89M 66.67M 66.61M 66.55M 66.35M 66.28M 66.22M
EPS (Basic)
-0.75 -0.66 -0.22 -0.63 -0.59 -0.59 -0.55 -0.5 -0.53 -0.45 -0.49 -0.53 -0.53 -0.49 -0.49 -0.5 -0.51 -0.46
EPS (Diluted)
-0.75 -0.66 -0.22 -0.63 -0.59 -0.59 -0.55 -0.5 -0.53 -0.45 -0.49 -0.53 -0.53 -0.49 -0.49 -0.5 -0.51 -0.46
EBITDA
-72.67M -64.7M -16.59M -53.78M -50.23M -48.89M -42.18M -37.98M -36.57M -33.5M -32.68M -35.31M -34.59M -32.28M -32.58M -33.21M -33.45M -30.48M
EBIT
-65.73M -57.59M -16.8M -53.99M -50.43M -49.13M -42.39M -38.2M -36.79M -33.7M -32.88M -35.5M -34.77M -32.45M -32.74M -33.37M -33.36M -30.59M
Depreciation & Amortization
224K -7.12M 204K 208K 202K 234K 214K 216K 213K 206K 206K 193K 183K 177K 166K 160K 124K 108K